NOS1 and Alzheimer disease: In AD patients, low levels of cGMP in the cerebrospinal fluid were found to correlate with the severity of memory impairment [41,42], and cerebral nNOS and eNOS immunohistochemical analysis revealed alterations in both enzymes.